retatrutide triple agonist clinical trials peptide Retatrutide Obesity Triple Agonist Targeting

Weight loss occurred primarily through reduced caloric intake facilitated by the medication's appetite-suppressing effects

This dual mechanism may lead to more significant and sustainable reductions in body fat, rather than weight loss primarily from lean tissue

I have stuck with it all these years

Additionally, GLP-1 receptors exist in blood vessel tissue and the central nervous system, suggesting direct vascular and sympathetic nervous system effects that may contribute to blood pressure modulation independent of weight loss alone

Melanotan II has higher hydrophobicity than most small peptides (due to D-Phe and Trp), so dissolution may be slightly slower